Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program Experience

BACKGROUND: Despite all the scientific progress that has been made on understanding the disease, prognosis for patients with relapsed and refractory Hodgkin's lymphoma remains poor and the treatment is palliative in the majority of the cases. Thus, the aim of this study was to present the resul...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Rev Bras Hematol Hemoter
Hoofdauteurs: Rocha, Talita Máira Bueno da Silveira da, Fortier, Sergio Costa, Fischer, Thais Rodrigues da Cunha, Perini, Guilherme Fleury, Gaiolla, Rafael Dezen, Fogliatto, Laura, Delamain, Marcia Torresan, Costa, Andressa Fragoso da, Castro, Nelson Siqueira de, Barretos, Wolney Gois, Souza, Cármino Antonio de, Buccheri, Valéria, Chiattone, Carlos Sérgio
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Sociedade Brasileira de Hematologia e Hemoterapia 2017
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5567422/
https://ncbi.nlm.nih.gov/pubmed/28830600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bjhh.2017.03.008
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items